In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma

In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma

Cong Xue,1 Ying Tian,2 Jing Zhang,3 Yuanyuan Zhao,1 Jianhua Zhan,2 Wenfeng Fang,1 Li Zhang1 1Department of Medical Oncology, 2Department of Research, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, 3Departmen...

Full description

Bibliographic Details
Main Authors: Xue C, Tian Y, Zhang J, Zhao YY, Zhan JH, Fang WF, Zhang L
Format: Article
Language:English
Published: Dove Medical Press 2016-03-01
Series:Drug Design, Development and Therapy
Subjects:
Nasopharyngeal carcinoma
EGFR
afatinib
gemcitabine
preclinical
Online Access:https://www.dovepress.com/in-vitro-and-in-vivo-efficacy-of-afatinib-as-a-single-agent-or-in-comb-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/in-vitro-and-in-vivo-efficacy-of-afatinib-as-a-single-agent-or-in-comb-peer-reviewed-article-DDDT

Similar Items